Drug Trial Radar · NCT00615303
The Effectiveness of Simethicone In Improving Visibility During Colonoscopy
Last checked: Nov 20, 2026Latest source record: Feb 22, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
194
Actual
Start
Dec 2006
Primary completion
Dec 2007
Study completion Dec 2007
Sponsor
- Lead sponsor
- Ramathibodi HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 14, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Sodium phosphate is one of the bowel preparation regimens for colonoscopy. However, intraluminal gas can impair visibility during the examination. Simethicone is medication that works by reducing the surface tension of air bubbles. We aimed to evaluate the effect of simethicone in enhancing visibility and efficacy during colonoscopy.
Conditions
- Colonoscopy
Interventions
SimethiconeDrug
2 dosages of either 45 ml of sodium phosphate plus 240 mg of simethicone tablets or 45 ml of sodium phosphate plus placebo in the evening before and in the morning of the procedure day. The colonoscopic examination was recorded
PlaceboDrug
2 dosages of either 45 ml of sodium phosphate plus 240 mg of simethicone tablets or 45 ml of sodium phosphate plus placebo in the evening before and in the morning of the procedure day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Visibility: air bubble and hazinessTime frame: During colonoscopy
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ramathibodi hospital
Bangkok, Bangkok, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.